🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Please consider participating in this study run by the fab Clarissa Schilstra, PhD and retweet if you know anyone who would be interested in participating 🙏 Michala Short Claire Wakefield PhD 🎗️ A/Prof Antoinette Anazodo OAM MD PHD Christina Signorelli, PhD

If you have a lived experience of cancer join us at this Community Conversation on the 13 Nov & help researchers better develop #RNA technologies to transform #cancer treatment bit.ly/3ZtQjza A $70 honorarium is offered

Really great to have been able to support this work.

At Telix, we are united by a common purpose – to help people living with cancer and rare diseases live longer, better quality lives. This year, more than 100,000 Telix doses were delivered to patients through our approved imaging agent, clinical trials and early access programs.

Wonderful to see Breanna in this graduation photo, being one of our PhD Top-Up Scholarship recipients. Onwards and upwards!!

We are absolutely thrilled to be able to congratulate our amazing colleague Georgia Halkett on her well-deserved promotion to the post of full Professor at Curtin University. Georgia, we are so proud to be working with you on so many worthwhile projects for our sarcoma community

World Cancer Day 2025

Wishing everyone a fantastic day today and a massive thank you for the support for the sarcoma community

🧬 Genetic Predisposition in Sarcoma Up to 20% #sarcoma may be assoc. with predisposition genes In our 📝 we review evidence on genetic predis. & how it may influence Rx decisions & management inc. surgery, radiotherapy, systemic Rx & surveillance 1/4 thelancet.com/journals/eclin…

To all of the nurses who work with such dedication within our sarcoma community - THANK YOU! ☺️

One of the many things about large scale precision oncology programs: they enable discovery of new entities. EP300::VGLL3 rhabdomyosarcoma: a potential distinct indolent adult rhabdomyosarcoma subtype - ESMO Rare Cancers esmorarecancers.org/article/S3050-… Omico Australia UNSW

This is a great project and we are really pleased to be able to support it. We would encourage you to add input towards a great future resource.